Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Curis and the Leukemia and Lymphoma Society agree to develop CUDC-907

Dec. 2, 2011

Medunik Canada acquires Canadian rights to two orphan therapies from QOL Medical

Dec. 2, 2011

Dainippon Sumitomo Pharma and Yoshitomiyakuhin to terminate antipsychotic drug copromotion agreement

Dec. 1, 2011

Idera Pharmaceuticals regains global rights to IMO-2055

Dec. 1, 2011

Companies collaborate on spinal muscular atrophy research

Dec. 1, 2011

OncoVista secures CRO for phase Ib study of cordycepin

Nov. 30, 2011

Infinity and Mundipharma extend strategic alliance for PI3K inhibitors

Nov. 30, 2011

Compugen and DiscoveRx collaborate on novel peptide ligands

Nov. 30, 2011

Proximagen and Altacor enter agreement for serotonin 5-HT2C program

Nov. 30, 2011

Exelixis signs CRADA for cabozantinib with National Cancer Institute

Nov. 29, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...